XML 27 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Operating activities:          
Net income (loss) $ (8,573) $ 1,604 $ (11,023) $ (17,240)  
Adjust for net (income) loss from discontinued operations (219) 183 (218) 4,049  
Adjustments to reconcile net loss to net cash used in operating activities:          
Stock-based compensation expense, net     1,057 1,389  
Bad debt expense     819 1,104 $ 1,841
Amortization of deferred revenue     (77) (35)  
Depreciation and amortization expense     10,462 10,890  
Accretion expense     119 0  
Change in fair value of interest rate swaps 3,234 (9,190) (3,175) (3,602)  
Change in fair value of warrant liabilities     (15) (148)  
Interest income related to SEMTH master lease agreement     (7,495) (1,394)  
Gain on disposal of assets     (1,452) (3,379)  
Change in operating right-of-use assets     23 (18)  
Amortization of debt discount and deferred financing costs     2,930 2,914  
Changes in operating assets and liabilities:          
Accounts receivable, net     (4,649) (5,240)  
Deferred rent assets     (701) 41  
Prepaid expenses and other current assets     4,775 (584)  
Other assets     2 126  
Accounts payable     297 387  
Accrued expenses and other current liabilities     (21,095) (5,898)  
Other long-term liabilities     (9) 8  
Deferred revenue     2,023 517  
Net cash used in continuing operating activities     (27,402) (16,113)  
Net cash provided by (used in) discontinued operating activities     100 (2,158)  
Net cash used in operating activities     (27,302) (18,271)  
Investing activities:          
Proceeds from sale of solar energy systems     2,853 3,631  
Proceeds from investment related to SEMTH master lease agreement     10,784 5,290  
Cash paid for acquisitions, net of cash acquired     0 (23,360)  
Purchases of other property and equipment     (150) (124)  
Net cash provided by (used in) continuing investing activities     13,487 (14,563)  
Net cash provided by discontinued investing activities     0 325  
Net cash provided by (used in) investing activities     13,487 (14,238)  
Financing activities:          
Repayments of long-term non-recourse debt     (136,750) (14,305)  
Proceeds from issuance of non-recourse debt     130,000 0  
Repayments under financing leases     0 (21)  
Payment of deferred financing costs     (2,108) 0  
Proceeds from issuance of common stock     0 150  
Proceeds from exercise of stock options     0 535  
Remittance of statutory tax withholding on stock-based payment awards     0 (17)  
Share repurchases     0 (1,614)  
Capital distributions to redeemable noncontrolling interests and noncontrolling interests     (140) (253)  
Net cash used in continuing financing activities     (8,998) (15,525)  
Net cash provided by discontinued financing activities     81 0  
Net cash used in financing activities     (8,917) (15,525)  
Net change in cash and cash equivalents and restricted cash:     (22,732) (48,034)  
Cash and cash equivalents and restricted cash, beginning of period     172,941 240,144 240,144
Cash and cash equivalents and restricted cash, end of period $ 150,209 $ 192,110 150,209 192,110 $ 172,941
Supplemental disclosure of cash flow information:          
Cash paid for interest     16,536 15,980  
Supplemental disclosures of noncash investing and financing information:          
Settlement of operating lease liability     $ 0 $ 1,170